Literature DB >> 21393182

Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08.

Nancy Bourdon1, Marguerite Fines-Guyon, Jean-Michel Thiolet, Sylvie Maugat, Bruno Coignard, Roland Leclercq, Vincent Cattoir.   

Abstract

OBJECTIVES: Unprecedented outbreaks of vancomycin-resistant enterococci (VRE) have occurred in French hospitals since 2004. The aim of this study was to provide a picture of the spread and control of VRE in France and to characterize the isolates.
METHODS: Notification of VRE cases to Institut de Veille Sanitaire has been mandatory since 2001. Isolates of VRE were sent to the National Reference Centre for species and vancomycin-resistance gene identification. Isolates were tested for antimicrobial susceptibility and typed by PFGE and multilocus sequence typing.
RESULTS: Five hundred and four VRE notifications from 195 hospitals were recorded, corresponding to 2475 cases of infection (n=243) or colonization (n=2232) and 74 episodes of clustered cases. Outbreaks were controlled by implementation of infection control measures, although the number of new hospitals reporting isolation of VRE was increasing. The majority of 902 VRE isolated from 2006 to 2008 were Enterococcus faecium (94.8%) with the vanA or vanB gene. No isolate was resistant to linezolid, tigecycline or fusidic acid. PFGE analysis showed 161 different patterns. Generally a few predominant clones and several minor clones spread in a single hospital. In a subset of 46 representatives of PFGE clones, 13 different sequence types were characterized, all belonging to clonal complex CC17, while the esp and hyl genes were inconsistently detected.
CONCLUSIONS: The national mandatory notification of unusual nosocomial events allowed rapid identification of VRE outbreaks and early implementation of control measures that have proved effective. However, VRE continue to emerge in a growing number of hospitals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393182     DOI: 10.1093/jac/dkq524

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  21 in total

1.  Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.

Authors:  Matthew J Neidell; Bevin Cohen; Yoko Furuya; Jennifer Hill; Christie Y Jeon; Sherry Glied; Elaine L Larson
Journal:  Clin Infect Dis       Date:  2012-06-14       Impact factor: 9.079

2.  Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.

Authors:  Hsih-Yeh Tsai; Chun-Hsing Liao; Yen-Hsu Chen; Po-Liang Lu; Cheng-Hua Huang; Chin-Te Lu; Yin-Ching Chuang; Shih-Ming Tsao; Yao-Shen Chen; Yung-Ching Liu; Wei-Yu Chen; Tsrang-Neng Jang; Hsiu-Chen Lin; Chih-Ming Chen; Zhi-Yuan Shi; Sung-Ching Pan; Jia-Ling Yang; Hsiang-Chi Kung; Chun-Eng Liu; Yu-Jen Cheng; Jien-Wei Liu; Wu Sun; Lih-Shinn Wang; Wen-Chien Ko; Kwok-Woon Yu; Ping-Cherng Chiang; Ming-Hsun Lee; Chun-Ming Lee; Gwo-Jong Hsu; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

3.  Probiotic Supplementation as an Emerging Alternative to Chemical Therapeutics in Finfish Aquaculture: a Review.

Authors:  Sufiara Yousuf; Anuj Tyagi; Rahul Singh
Journal:  Probiotics Antimicrob Proteins       Date:  2022-07-29       Impact factor: 5.265

4.  Molecular epidemiology of vancomycin-resistant enterococci isolated from non-tertiary-care and tertiary-care hospitals in Korea.

Authors:  M K Jung; S H Ahn; W G Lee; E H Lee
Journal:  Epidemiol Infect       Date:  2014-11       Impact factor: 4.434

5.  Changes in enterococcal populations and related antibiotic resistance along a medical center-wastewater treatment plant-river continuum.

Authors:  Roland Leclercq; Kenny Oberlé; Sébastien Galopin; Vincent Cattoir; Hélène Budzinski; Fabienne Petit
Journal:  Appl Environ Microbiol       Date:  2013-02-01       Impact factor: 4.792

6.  High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland.

Authors:  E Sadowy; A Sieńko; I Gawryszewska; A Bojarska; K Malinowska; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-05       Impact factor: 3.267

7.  Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Enterococci with low- and medium-level VanB-type vancomycin resistance: a multicenter study.

Authors:  Kristin Hegstad; Christian G Giske; Bjørg Haldorsen; Erika Matuschek; Kristian Schønning; Truls M Leegaard; Gunnar Kahlmeter; Arnfinn Sundsfjord
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

8.  Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies.

Authors:  Panayiotis D Ziakas; Rachana Thapa; Louis B Rice; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

9.  Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU.

Authors:  Guido Werner; Ingo Klare; Carola Fleige; Uta Geringer; Wolfgang Witte; Heinz-Michael Just; Renate Ziegler
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-30       Impact factor: 4.887

Review 10.  The human gut resistome.

Authors:  Willem van Schaik
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.